GT Biopharma (GTBP) | Q2 2015 | 1,778,503,896.82% |
Ascent Solar Technologies, Inc Common Stock (ASTI) | Q2 2015 | 99,999,899.99% |
CleanSpark (CLSK) | Q2 2015 | 900% |
FiEE (FIEE) | Q2 2015 | 398.89% |
Viewbix Inc Common Stock (VBIX) | Q2 2015 | 397.78% |
Quantum X Labs (QXL) | Q2 2015 | 397.78% |
Marker Therapeutics (MRKR) | Q2 2015 | 357.14% |
Metalla Royalty & Streaming (MTA) | Q2 2015 | 200% |
Mawson Infrastructure (MIGI) | Q2 2015 | 171.43% |
Yueda Digital (YDKG) | Q2 2015 | 145.45% |
Altisource Portfolio Solutions (ASPS) | Q2 2015 | 140.17% |
Tantech (TANH) | Q2 2015 | 135.62% |
AlphaTON Capital (ATON) | Q2 2015 | 133.33% |
Alpha Compute (ALP) | Q2 2015 | 133.33% |
Natural Health Trend (NHTC) | Q2 2015 | 133.15% |
SOLAI (SLAI) | Q2 2015 | 129.3% |
Celsius (CELH) | Q2 2015 | 126.37% |
Sarepta Therapeutics (SRPT) | Q2 2015 | 115.36% |
Lakefront Biotherapeutics (LKFT) | Q2 2015 | 115.35% |
Heron Therapeuti (HRTX) | Q2 2015 | 115.34% |
Nomad Foods (NOMD) | Q2 2015 | 114.01% |
Bimergen Energy (BESS) | Q2 2015 | 112% |
Enveric Biosciences (ENVB) | Q2 2015 | 110.33% |
Digimarc (DMRC) | Q2 2015 | 105.74% |
Anavex Life Sciences (AVXL) | Q2 2015 | 105.48% |
